Growing community of inventors

Tokorozawa, Japan

Masami Muramatsu

Average Co-Inventor Count = 4.22

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 159

Masami MuramatsuTadatsugu Taniguchi (8 patents)Masami MuramatsuHaruo Sugano (8 patents)Masami MuramatsuHiroshi Matsui (5 patents)Masami MuramatsuNobukazu Kashima (5 patents)Masami MuramatsuJunji Hamuro (4 patents)Masami MuramatsuYataro Ichikawa (2 patents)Masami MuramatsuYoshihiko Sumi (2 patents)Masami MuramatsuNobuo Aoki (2 patents)Masami MuramatsuMasami Muramatsu (10 patents)Tadatsugu TaniguchiTadatsugu Taniguchi (23 patents)Haruo SuganoHaruo Sugano (17 patents)Hiroshi MatsuiHiroshi Matsui (46 patents)Nobukazu KashimaNobukazu Kashima (6 patents)Junji HamuroJunji Hamuro (22 patents)Yataro IchikawaYataro Ichikawa (46 patents)Yoshihiko SumiYoshihiko Sumi (15 patents)Nobuo AokiNobuo Aoki (14 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ajinomoto Co., Ltd. (5 from 1,929 patents)

2. Juridical Foundation, Japanese Foundation for Cancer Research (3 from 8 patents)

3. Teijin Limited (2 from 1,586 patents)

4. Japanese Foundation for Cancer Research (2 from 55 patents)


10 patents:

1. 9376478 - DNA and recombinant plasmid

2. 5795777 - Gene coded for interleukin-2 polypeptide, recombinant DNA carrying the

3. 5795769 - Gene encoding interleukin-2 polypeptide, recombinant DNA carrying the

4. 5700913 - Unglycosylated human interleukin-2 polypeptides

5. 5620868 - Gene coded for interleukin-2 polypeptide, recombinant DNA carrying the

6. 5576193 - Protein having human plasmin inhibiting activity

7. 5514567 - DNA and recombinant plasmid

8. 5463025 - Protein having human plasmin inhibiting activity

9. 5326859 - DNA and recombinant plasmid

10. 4738927 - Gene coded for interleukin-2 polypeptide, recombinant DNA carrying the

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/9/2025
Loading…